NVOS — Novo Integrated Sciences Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeMicro CapValue Trap

Annual balance sheet for Novo Integrated Sciences, fiscal year end - August 31st, USD millions except per share, conversion factor applied.

	2020 August 31st	2021 August 31st	2022 August 31st	2023 August 31st	2024 August 31st
Period Length:	—	—	—	—	—
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Cash and Short Term Investments	2.07	8.29	2.18	0.416	0.845
Net Total Accounts Receivable
Net Total Receivables	2.04	2.28	2.1	2.52	3.15
Total Inventory
Prepaid Expenses
Total Current Assets	4.29	11.1	5.73	4.39	5.41
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	3.16	8.61	8.47	7.37	6.8
Net Goodwill
Net Intangible Assets
Long Term Investments
Long Term Notes Receivable
Other Long Term Assets
Total Assets	35.4	62	40.9	35.6	32.1
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	2.6	8.46	14.1	7.9	14.6
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Deferred Income Tax
Minority Interest
Total Other Liabilities
Total Liabilities	5.77	18.1	18.6	10.7	17.2
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	29.6	43.9	22.3	24.8	14.9
Total Liabilities & Shareholders' Equity	35.4	62	40.9	35.6	32.1
Total Common Shares Outstanding
Total Preferred Shares Outstanding